356 related articles for article (PubMed ID: 32427336)
1. Rationally designed peptide-based inhibitor of Aβ42 fibril formation and toxicity: a potential therapeutic strategy for Alzheimer's disease.
Horsley JR; Jovcevski B; Wegener KL; Yu J; Pukala TL; Abell AD
Biochem J; 2020 Jun; 477(11):2039-2054. PubMed ID: 32427336
[TBL] [Abstract][Full Text] [Related]
2. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
Gu L; Tran J; Jiang L; Guo Z
J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
[TBL] [Abstract][Full Text] [Related]
3. Sclerotiorin Stabilizes the Assembly of Nonfibrillar Abeta42 Oligomers with Low Toxicity, Seeding Activity, and Beta-sheet Content.
Wiglenda T; Groenke N; Hoffmann W; Manz C; Diez L; Buntru A; Brusendorf L; Neuendorf N; Schnoegl S; Haenig C; Schmieder P; Pagel K; Wanker EE
J Mol Biol; 2020 Mar; 432(7):2080-2098. PubMed ID: 32061932
[TBL] [Abstract][Full Text] [Related]
4. Scrutiny of the mechanism of small molecule inhibitor preventing conformational transition of amyloid-β
Shuaib S; Goyal B
J Biomol Struct Dyn; 2018 Feb; 36(3):663-678. PubMed ID: 28162045
[TBL] [Abstract][Full Text] [Related]
5. Internalisation and toxicity of amyloid-β 1-42 are influenced by its conformation and assembly state rather than size.
Vadukul DM; Maina M; Franklin H; Nardecchia A; Serpell LC; Marshall KE
FEBS Lett; 2020 Nov; 594(21):3490-3503. PubMed ID: 32871611
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic insights into the mitigation of Aβ aggregation and protofibril destabilization by a D-enantiomeric decapeptide rk10.
Singh K; Kaur A; Goyal D; Goyal B
Phys Chem Chem Phys; 2022 Sep; 24(36):21975-21994. PubMed ID: 36069400
[TBL] [Abstract][Full Text] [Related]
7. SEVI Inhibits Aβ Amyloid Aggregation by Capping the β-Sheet Elongation Edges.
Wang Y; Xu J; Huang F; Yan J; Fan X; Zou Y; Wang C; Ding F; Sun Y
J Chem Inf Model; 2023 Jun; 63(11):3567-3578. PubMed ID: 37246935
[TBL] [Abstract][Full Text] [Related]
8. The conformational epitope for a new Aβ42 protofibril-selective antibody partially overlaps with the peptide N-terminal region.
Colvin BA; Rogers VA; Kulas JA; Ridgway EA; Amtashar FS; Combs CK; Nichols MR
J Neurochem; 2017 Dec; 143(6):736-749. PubMed ID: 28881033
[TBL] [Abstract][Full Text] [Related]
9. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
Dong M; Zhao W; Hu D; Ai H; Kang B
ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
[TBL] [Abstract][Full Text] [Related]
10. Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data.
Kocis P; Tolar M; Yu J; Sinko W; Ray S; Blennow K; Fillit H; Hey JA
CNS Drugs; 2017 Jun; 31(6):495-509. PubMed ID: 28435985
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Novel Multifunctional Ligand for Simultaneous Inhibition of Amyloid-Beta (Aβ
Asadbegi M; Shamloo A
ACS Chem Neurosci; 2019 Nov; 10(11):4619-4632. PubMed ID: 31566950
[TBL] [Abstract][Full Text] [Related]
12. Computationally Designed Small Molecules Disassemble Both Soluble Oligomers and Protofibrils of Amyloid β-Protein Responsible for Alzheimer's Disease.
Jin Y; Downey MA; Singh A; Buratto SK; Bowers MT
ACS Chem Neurosci; 2023 Aug; 14(15):2717-2726. PubMed ID: 37442126
[TBL] [Abstract][Full Text] [Related]
13. EPR Studies of Aβ42 Oligomers Indicate a Parallel In-Register β-Sheet Structure.
Jang C; Portugal Barron D; Duo L; Ma C; Seabaugh H; Guo Z
ACS Chem Neurosci; 2024 Jan; 15(1):86-97. PubMed ID: 38109787
[TBL] [Abstract][Full Text] [Related]
14. A traditional Chinese Medicine, YXQN, Reduces Amyloid-induced Cytotoxicity by Inhibiting Aβ42 Aggregation and Fibril Formation.
Wang L; Liu S; Xu J; Watanabe N; Di J; Wei W; Mayo KH; Li J; Li X
Curr Pharm Des; 2020; 26(7):780-789. PubMed ID: 32031066
[TBL] [Abstract][Full Text] [Related]
15. Amyloid Fibril Formation of Arctic Amyloid-β 1-42 Peptide is Efficiently Inhibited by the BRICHOS Domain.
Zhong X; Kumar R; Wang Y; Biverstål H; Ingeborg Jegerschöld C; J B Koeck P; Johansson J; Abelein A; Chen G
ACS Chem Biol; 2022 Aug; 17(8):2201-2211. PubMed ID: 35876740
[TBL] [Abstract][Full Text] [Related]
16. Triazole-Peptide Conjugate as a Modulator of Aβ-Aggregation, Metal-Mediated Aβ-Aggregation, and Cytotoxicity.
Mann S; Kaur A; Kaur A; Priyadarshi N; Goyal B; Singhal NK; Goyal D
ACS Chem Neurosci; 2023 May; 14(9):1631-1645. PubMed ID: 37040092
[TBL] [Abstract][Full Text] [Related]
17. Increased Secondary Nucleation Underlies Accelerated Aggregation of the Four-Residue N-Terminally Truncated Aβ42 Species Aβ5-42.
Weiffert T; Meisl G; Flagmeier P; De S; Dunning CJR; Frohm B; Zetterberg H; Blennow K; Portelius E; Klenerman D; Dobson CM; Knowles TPJ; Linse S
ACS Chem Neurosci; 2019 May; 10(5):2374-2384. PubMed ID: 30793584
[TBL] [Abstract][Full Text] [Related]
18. Structural differences of amyloid-β fibrils revealed by antibodies from phage display.
Droste P; Frenzel A; Steinwand M; Pelat T; Thullier P; Hust M; Lashuel H; Dübel S
BMC Biotechnol; 2015 Jun; 15():57. PubMed ID: 26084577
[TBL] [Abstract][Full Text] [Related]
19. Novel Disassembly Mechanisms of Sigmoid Aβ
Xing X; Liu C; Ali A; Kang B; Li P; Ai H
ACS Chem Neurosci; 2020 Jan; 11(1):45-56. PubMed ID: 31697060
[TBL] [Abstract][Full Text] [Related]
20. Toward the Mode of Action of the Clinical Stage All-d-Enantiomeric Peptide RD2 on Aβ42 Aggregation.
Zhang T; Gering I; Kutzsche J; Nagel-Steger L; Willbold D
ACS Chem Neurosci; 2019 Dec; 10(12):4800-4809. PubMed ID: 31710458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
